Sponsor pipeline

Reshma L. Mahtani, D.O. clinical trial pipeline

Get alerts when Reshma L. Mahtani, D.O.'s trials change

1 active trials 1 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-13
Primary completion pushed: 2026-06 → 2028-06
Completion pushed: 2026-12 → 2028-12
NCT06263543 Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC · Phase 2

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06263543 Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC Breast Cancer Recruiting 2026-08-12

Disease areas by active trials

Breast Cancer (1)

Get alerts when Reshma L. Mahtani, D.O.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free